Does APIXABAN Cause Nasopharyngitis? 750 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 750 reports of Nasopharyngitis have been filed in association with APIXABAN (ELIQUIS). This represents 0.5% of all adverse event reports for APIXABAN.
750
Reports of Nasopharyngitis with APIXABAN
0.5%
of all APIXABAN reports
2
Deaths
126
Hospitalizations
How Dangerous Is Nasopharyngitis From APIXABAN?
Of the 750 reports, 2 (0.3%) resulted in death, 126 (16.8%) required hospitalization, and 5 (0.7%) were considered life-threatening.
Is Nasopharyngitis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for APIXABAN. However, 750 reports have been filed with the FAERS database.
What Other Side Effects Does APIXABAN Cause?
Death (18,501)
Cerebrovascular accident (7,237)
Atrial fibrillation (5,690)
Off label use (5,590)
Thrombosis (5,298)
Fall (5,063)
Cardiac disorder (4,917)
Haemorrhage (4,770)
Dyspnoea (4,379)
Gastrointestinal haemorrhage (4,030)
What Other Drugs Cause Nasopharyngitis?
ADALIMUMAB (13,753)
ETANERCEPT (12,421)
METHOTREXATE (8,046)
TOFACITINIB (7,781)
SECUKINUMAB (7,022)
TOCILIZUMAB (6,664)
RITUXIMAB (6,321)
ABATACEPT (6,143)
INFLIXIMAB (5,353)
CERTOLIZUMAB PEGOL (5,295)
Which APIXABAN Alternatives Have Lower Nasopharyngitis Risk?
APIXABAN vs APOMORPHINE
APIXABAN vs APRACLONIDINE
APIXABAN vs APREMILAST
APIXABAN vs APREPITANT
APIXABAN vs APROTININ